MicroVision MOVIA lidar gains support on NVIDIA DRIVE AGX platform
LONDON - EMV Capital Plc (AIM:EMVC), a venture capital investment group specializing in deep tech and life sciences, has reported its preliminary results for the year ended December 31, 2024. The company announced a revenue increase to £2.5 million from £1.4 million the previous year, with new fund management fees contributing to this growth. Despite the revenue increase, the group experienced a net loss of £3.7 million, up from £2.9 million in 2023.
The company’s total assets under management (AUM) saw a significant rise of 33% to £98.5 million, up from £74.0 million in 2023. The fair value of direct holdings increased by 6% to £37.7 million, while managed and third-party holdings saw an approximate 58% increase to £60.8 million. As of May 31, 2025, the total AUM further increased to £103 million, reflecting fair value uplift from portfolio transactions and a follow-on fundraising by Martlet Capital.
EMV Capital successfully executed a £1.5 million share placement at a 15% premium in December 2024, with substantial participation from directors and management. The group’s investment strategy, which focuses on capital efficiency, was highlighted by the performance of subsidiary portfolio companies ProAxsis and Glycotest, which were funded by external investors, alleviating the cash burden on group operations.
The group’s portfolio has expanded to over 70 companies, with significant amounts raised by portfolio companies through equity and debt. The company’s CEO, Dr. Ilian Iliev, expressed confidence in the group’s resilience against macroeconomic challenges and its potential for delivering long-term value to shareholders.
EMV Capital will hold a live online presentation for investors on June 12, 2025, to discuss these results and the company’s outlook. The presentation will be accessible through the Investor Meet Company platform, where investors can submit questions in advance or during the live event.
This financial update is based on a press release statement from EMV Capital Plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.